Insights

Strategic Funding ImVitro recently closed a $2.5M seed round led by LDV Capital with co-investors including MMC Ventures, Tiny VC, Fly Ventures, and Compound VC, signaling investor confidence and potential for follow-on funding rounds to support growth and platform development.

AI for IVF The core value proposition centers on using artificial intelligence to improve IVF transparency, robustness, and reproducibility, addressing a critical efficiency gap in European clinics where current success rates are 20-30% and repeat procedures are common.

Early Stage Opportunity As an early-stage deep-tech startup with a small team (2-10 employees) and pre-seed backing, there is clear room for enterprise partnerships with fertility clinics and medical device manufacturers looking to co-develop AI-enabled IVF solutions.

Tech Stack & Partners Utilizing cloud and collaboration tools (AWS, Amplitude, GitHub, Docker, Notion, Slack) alongside Trustpilot for social proof suggests readiness for scalable product development, data analytics, and customer success integration with clinics and healthcare platforms.

Growth Signals Seed funding announcement coverage from multiple outlets and the company’s aim to reduce repeat IVF cycles positions ImVitro as a potential partner for clinics, payers, and research institutions seeking cost reductions, improved outcomes, and data-driven fertility workflows.

Similar companies to ImVitro

ImVitro Tech Stack

ImVitro uses 8 technology products and services including Amplitude, Amazon Web Services, GitHub, and more. Explore ImVitro's tech stack below.

ImVitro's Email Address Formats

ImVitro uses at least 1 email format:
ImVitro Email FormatsExamplePercentage
First@im-vitro.comJohn@im-vitro.com
100%

Frequently Asked Questions

What is ImVitro's official website and social media links?

Minus sign iconPlus sign icon
ImVitro's official website is im-vitro.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ImVitro generate?

Minus sign iconPlus sign icon
As of September 2026, ImVitro's annual revenue is estimated to be <$1M.

What is ImVitro's NAICS code?

Minus sign iconPlus sign icon
ImVitro's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does ImVitro have currently?

Minus sign iconPlus sign icon
As of September 2026, ImVitro has approximately 4 employees across 2 continents, including Europe and North America. Key team members include Leader Computer Vision Engineer: G. C. Explore ImVitro's employee directory with LeadIQ.

What industry does ImVitro belong to?

Minus sign iconPlus sign icon
ImVitro operates in the Medical Equipment Manufacturing industry.

What technology does ImVitro use?

Minus sign iconPlus sign icon
ImVitro's tech stack includes Amplitude, Amazon Web Services, GitHub, Docker, Figma, Trustpilot, Notion and Slack.

What is ImVitro's email format?

Minus sign iconPlus sign icon
ImVitro's email format typically follows the pattern of First@im-vitro.com. Find more ImVitro email formats with LeadIQ.

How much funding has ImVitro raised to date?

Minus sign iconPlus sign icon
As of September 2026, ImVitro has raised $2.5M in funding. The last funding round occurred on Dec 05, 2022 for $2.5M.

When was ImVitro founded?

Minus sign iconPlus sign icon
ImVitro was founded in 2019.
ImVitro logo

ImVitro

Medical Equipment ManufacturingÎle-de-France, France2-10 Employees

ImVitro is a Paris-based early-stage Deep Tech startup focused on advancing in vitro fertilization through artificial intelligence, aiming to make IVF more transparent, robust, and reproducible for patients and clinics. The company targets individuals facing fertility issues and seeks to reduce the emotional and financial burden of repeated IVF cycles by improving outcomes and consistency. Operating within the medical equipment manufacturing sector, ImVitro positions itself at the intersection of healthcare technology and fertility treatment, with a goal of addressing a key challenge in Europe where IVF success rates are relatively modest. The organization is based in Paris, Île-de-France, and has established itself as a small, growth-oriented enterprise planning to scale its offerings from a modular, patient-centered perspective. A notable recent development is its involvement with a seed-round-backed expansion led by a broad group of early-stage investors as part of its early-stage growth trajectory.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • $2.5M

    ImVitro has raised a total of $2.5M of funding over 3 rounds. Their latest funding round was raised on Dec 05, 2022 in the amount of $2.5M as a Seed.

  • <$1M

    ImVitro's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.